Apixaban causes increased bleeding, but reduced ischemic events in patients with recent acute coronary syndrome: Results of the APPRAISE-1 Trial

Revision as of 05:06, 16 February 2009 by Jacki Buros (talk | contribs) (Apixaban causes increased bleeding, but reduced ischemic events in patients with recent acute coronary syndrome: Results of the APPRAISE-1 Trial moved to [[News:Apixaban causes increased bleeding, but reduced ischemic events in patients with recent ac)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Redirect page
Jump to navigation Jump to search